Ad is loading...
MVCAX
Price
$36.21
Change
+$0.34 (+0.95%)
Updated
Nov 22 closing price
NCVLX
Price
$13.27
Change
+$0.15 (+1.14%)
Updated
Nov 22 closing price
Ad is loading...

MVCAX vs NCVLX

Header iconMVCAX vs NCVLX Comparison
Open Charts MVCAX vs NCVLXBanner chart's image
MFS Mid Cap Value A
Price$36.21
Change+$0.34 (+0.95%)
VolumeN/A
CapitalizationN/A
Nuance Concentrated Value Institutional
Price$13.27
Change+$0.15 (+1.14%)
VolumeN/A
CapitalizationN/A
MVCAX vs NCVLX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MVCAX vs. NCVLX commentary
Nov 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MVCAX is a Buy and NCVLX is a StrongBuy.

FUNDAMENTALS
Fundamentals
MVCAX has more cash in the bank: 18.3B vs. NCVLX (175M). NCVLX pays higher dividends than MVCAX: NCVLX (1.75) vs MVCAX (1.16). MVCAX was incepted earlier than NCVLX: MVCAX (23 years) vs NCVLX (13 years). NCVLX is a more actively managed with annual turnover of: 67.00 vs. MVCAX (19.00). MVCAX has a lower initial minimum investment than NCVLX: MVCAX (1000) vs NCVLX (10000). MVCAX annual gain was more profitable for investors over the last year : 29.13 vs. NCVLX (17.39). MVCAX return over 5 years is better than : 54.99 vs. NCVLX (-7.54).
MVCAXNCVLXMVCAX / NCVLX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence23 years13 years-
Gain YTD21.3887.731277%
Front LoadN/AN/A-
Min. Initial Investment10001000010%
Min. Initial Investment IRAN/AN/A-
Net Assets18.3B175M10,457%
Annual Yield % from dividends1.161.7566%
Returns for 1 year29.1317.39168%
Returns for 3 years12.33-14.11-87%
Returns for 5 years54.99-7.54-729%
Returns for 10 years81.571.326,158%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BCDA2.260.12
+5.85%
BioCardia Inc.
OR20.110.25
+1.26%
Osisko Gold Royalties Ltd
AVXL9.110.09
+1.00%
Anavex Life Sciences Corp
TRU99.130.54
+0.54%
TransUnion
NBTX3.79-0.04
-1.09%
Nanobiotix SA